Company news

Pharmaceutical promotion measurement firm ImpactRx has acquired Paragon Research & Consulting, Inc. of West Chester, PA. Paragon is expected to apply its analytical and custom research capabilities to ImpactRx's proprietary data to evaluate of the pharmaceutical market and of individual company and brand performance.

Teva Pharmaceutical Industries announced it has entered into a definitive agreement to acquire CoGenesys, a privately held biopharmaceutical company with a broad based biotechnology platform and focused on the development of peptide- and protein-based medicines across broad therapeutic categories. CoGenesys was established in 2005 as a division within Human Genome Sciences Inc. to focus on early drug development and was spun off as an independent company in June 2006.

You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.